News - North America


Current filters:

North America

Popular Filters

1810 to 1834 of 1895 results

US FDA approves Bristol-Myers Squibb’s Nulojix for kidney transplant patients


In a much anticipated move following a positive 13 to five advisory committee vote (The Pharma Letter…

belataceptBristol-Myers SquibbImmunologicalsNorth AmericaNulojixPharmaceuticalRegulation

Bladder cancer risk of Takeda’s Actos now highlighted by US FDA


The latest bad news for Japan’s largest drugmaker, Takeda Pharmaceutical (TYO: 4502) came last night…

ActosDiabetesNorth AmericaPharmaceuticalRegulationTakeda Pharmaceuticals

Boehringer Ingelheim and Lilly begin US roll-out of diabetes drug Tradjenta


German independent drug major Boehringer Ingelheim and USA-based Eli Lilly (NYSE: LLY) announced yesterday…

Boehringer IngelheimDiabetesEli LillyMarkets & MarketingNorth AmericaPharmaceuticalTradjenta

US generics group GPhA voices worries on TPP agreement negotiations


The USA’s Generic Pharmaceutical Association (GPhA) says that it has sent a letter to President…

BiotechnologyGenericsMarkets & MarketingNorth AmericaPatents

Dr Reddy’s warned by US FDA over API facility in Mexico


Indian generic drug major Dr Reddy’s Laboratories (NYSE:RDY) revealed yesterday that its wholly-owned…

Dr Reddy's LaboratoriesGenericsNorth AmericaRegulationSouth America

US pharma has 277 medicines in development for skin diseases


The USA’s biopharmaceutical research companies currently are developing 277 medicines to help the…

DermatologicalsNorth AmericaPharmaceuticalResearch

Abbott Labs sued over debilitating side effect with Humira


A law suit has been filed against US health care major Abbott Laboratories (NYSE: ABT) in a US federal…

Abbott LaboratoriesAnti-Arthritics/RheumaticsHumiraLegalNorth AmericaPharmaceutical

US FDA warns on risk of more serious forms of prostate cancer with 5-ARI drugs


The US Food and Drug Administration has warned that the labeling for drugs used to treat enlarged prostate…

AvodartGlaxoSmithKlineMerck & CoNorth AmericaOncologyPharmaceuticalProscarRegulation

Gilead Sciences subpoenaed in USA over HIV and other drugs


US biopharmaceutical company Gilead Sciences (Nasdaq: GILD) revealed late Friday that it has received…

Anti-viralsAtriplaBiotechnologyGilead SciencesLegalNorth AmericaPharmaceuticalTruvada

GlaxoSmithKline and Valeant get FDA approval for epilepsy drug Potiga


Following backing from a US Food and Drug Administration advisory panel last summer (The Pharma Letter…

GlaxoSmithKlineNeurologicalNorth AmericaPharmaceuticalPotigaRegulationTrobaltValeant Pharmaceuticals

US FDA working to lessen drug shortage impact


Last year, the number of drug shortages in the USA reached a record high, and medicine scarcities have…

Markets & MarketingNorth AmericaPharmaceuticalRegulation

Pfizer to invest $100 million in Boston area academia for therapeutic innovation


New York-based Pfizer (NYSE: PFE), the world’s largest drugmaker by sales, says its network of translational…

FinancialNorth AmericaPfizerPharmaceuticalResearch

Judge vacates Amylin injunction against Eli Lilly; latter updates Humalog label


It was a good news day for US drug major Eli Lilly (NYSE: LLY) yesterday, as the firm received approval…

AmylinBoehringer IngelheimDiabetesEli LillyExenatide InjectionHumalogLegallinagliptinNorth AmericaPharmaceuticalRegulation

US FDA curbs use of high-dose simvastatin, citing increased risk of muscle injury


The US Food and Drug Administration yesterday announced safety label changes for the cholesterol-lowering…

Abbott LaboratoriesCardio-vascularMerck & CoNorth AmericaPharmaceuticalRegulationSimcorSimvastatinZocor

CETA with EU would wipe out Canada’s drug savings, says generic drugmakers, but Rx& D sees benefits


The European Union is in negotiations for a comprehensive economic and trade agreement (CETA) with Canada.…

EuropeGenericsMarkets & MarketingNorth AmericaPatentsPharmaceuticalPolitics

Changing of the Guard begins in biotech sector


The biotechnology sector is bracing for change this year as a flurry of "biosimilar" or "biogeneric"…

BiotechnologyGenericsMarkets & MarketingNorth AmericaRegulation

Battle for share of US $8.5 billion in vitro diagnostic market


The US in-vitro diagnostic market, including immunochemistry, molecular diagnostics, point-of-care testing,…

Abbott LaboratoriesMarkets & MarketingNorth AmericaPharmaceuticalRoche

FDA accepts ciclesonide NDA from Nycomed partner Sunovion


Swiss drugmaker Nycomed, the subject of a $13.7 billion takeover bid from Japan’s Takeda (TYO:4502;…

Ciclesonide Inhalation AerosolNorth AmericaNycomedPharmaceuticalRegulationRespiratory and PulmonarySunovion

Blow for Orexigen as regulatory demands see firm put obesity drug Contrave on hold


Shares of US biotech firm Orexigen Therapeutics (Nasdaq: OREX) plunged 33% to $2.13 by afternoon trading…

ContraveMetabolicsNorth AmericaOrexigen TherapeuticsPharmaceuticalRegulation

Johnson & Johnson faces $327 million penalty over Risperdal marketing


Civil penalties amounting to just over $327 million have been announced in the case of State of South…

Johnson & JohnsonLegalNeurologicalNorth AmericaOrtho-McNeil-JanssenPharmaceuticalRisperdal

US Biotech posts small gain in May, says Burrill


It was a quiet month for US biotech with the Burrill Biotech Select Index recording a small 2.8% gain…

BiotechnologyFinancialNorth America

1810 to 1834 of 1895 results

Company Spotlight



Back to top